Optimark Evropska unija - slovenščina - EMA (European Medicines Agency)

optimark

mallinckrodt deutschland gmbh - gadoversetamide - slikanje z magnetno resonanco - kontrastni mediji - to zdravilo je samo za diagnostično uporabo. optimark je primerna za uporabo z magnetno resonanco (mri) centralnega živčnega sistema (cns) in jetra. to zagotavlja kontrast opremo in omogoča vizualizacijo in pomaga pri opredelitvi informacijskih poškodbah in nenormalno struktur v cns in jeter pri bolnikih z znano ali zelo sum patologija.

TruScient Evropska unija - slovenščina - EMA (European Medicines Agency)

truscient

zoetis belgium sa - dibotermin alfa - morfogenetski proteini kosti - psi - osteoinduktivno sredstvo za uporabo pri zdravljenju zlomov z dolgimi kostmi kot dodatka k standardni kirurški posegi z uporabo zmanjšane odpovedi zlomov pri psih.

Comirnaty Evropska unija - slovenščina - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cepiva - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.

Beloderm 0,5 mg/g dermalna raztopina Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

beloderm 0,5 mg/g dermalna raztopina

belupo, d.o.o., ljubljana - betametazon - dermalna raztopina - betametazon 0,5 mg / 1 g - betametazon

Beloderm 0,5 mg/g dermalna raztopina Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

beloderm 0,5 mg/g dermalna raztopina

belupo, d.o.o., ljubljana - betametazon - dermalna raztopina - betametazon 0,5 mg / 1 g - betametazon

Beloderm 0,5 mg/g dermalna raztopina Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

beloderm 0,5 mg/g dermalna raztopina

belupo, d.o.o., ljubljana - betametazon - dermalna raztopina - betametazon 0,5 mg / 1 g - betametazon

Advantan 1 mg/g dermalna emulzija Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

advantan 1 mg/g dermalna emulzija

bayer d.o.o. - metilprednizolonaceponat - dermalna emulzija - metilprednizolonaceponat 1 mg / 1 g - metilprednizolonaceponat

BELOSALIC 0,5 mg / 20 mg v 1 g dermalna raztopina Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

belosalic 0,5 mg / 20 mg v 1 g dermalna raztopina

belupo, d.o.o., ljubljana - betametazon; salicilna kislina - dermalna raztopina - betametazon 0,5 mg / 1 g  salicilna kislina20 mg / 1 g; salicilna kislina 20 mg / 1 g - betametazon

BELOSALIC 0,5 mg / 20 mg v 1 g dermalna raztopina Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

belosalic 0,5 mg / 20 mg v 1 g dermalna raztopina

belupo, d.o.o., ljubljana - betametazon; salicilna kislina - dermalna raztopina - betametazon 0,5 mg / 1 g  salicilna kislina20 mg / 1 g; salicilna kislina 20 mg / 1 g - betametazon

Canifug 10 mg/1 ml dermalno pršilo, raztopina Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

canifug 10 mg/1 ml dermalno pršilo, raztopina

dr. a. wolff - klotrimazol - dermalno pršilo, raztopina - klotrimazol 10 mg / 1 ml - klotrimazol